Hardek Patel Selected Research

3- (3- carboxybenzyl)- 1- ((6- ethylbenzo(d)(1,3)dioxol- 5- yl)methyl)- 6- hydroxy- 4- oxo- 1,4- dihydroquinoline- 2- carboxylic acid

1/2018	Transient Blockade of Endothelin-1 Mitigates Amiodarone-Induced Pulmonary Fibrosis.
1/2017	Time-dependent effects of HJP272, an endothelin receptor antagonist, in bleomycin-induced pulmonary fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hardek Patel Research Topics

Disease

2	Lung Injury 01/2018 - 01/2017
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 01/2017
1	Pneumonia (Pneumonitis) 01/2018
1	Acute Lung Injury 01/2017

Drug/Important Bio-Agent (IBA)

2	Chemokine CXCL12IBA 01/2018 - 01/2017
2	Endothelin-1 (Endothelin 1)IBA 01/2018 - 01/2017
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018 - 01/2017
2	3- (3- carboxybenzyl)- 1- ((6- ethylbenzo(d)(1,3)dioxol- 5- yl)methyl)- 6- hydroxy- 4- oxo- 1,4- dihydroquinoline- 2- carboxylic acidIBA 01/2018 - 01/2017
2	Endothelin Receptor AntagonistsIBA 01/2018 - 01/2017
2	CollagenIBA 01/2018 - 01/2017
2	Becaplermin (PDGF-BB)FDA Link 01/2018 - 01/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2018
1	Amiodarone (Amiodarona)FDA LinkGeneric 01/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2017
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2017
1	indium-bleomycinIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2017